Education
About Us
Working with TipRanks
Follow Us
Estrella Immunopharma (ESLA)
NASDAQ:ESLA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -8.85M | $ -7.31M | $ -1.57M | $ -1.69M | $ -733.69K |
| EBITDA | $ -8.85M | $ -7.31M | $ -686.97K | $ -11.16K | $ -733.69K |
| Net Income | $ -8.85M | $ -7.31M | $ -996.10K | $ -1.69M | $ -733.69K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 916.92K | $ 4.17M | $ 40.80K | $ 4.09M | $ 0.00 |
| Total Assets | $ 3.14M | $ 4.45M | $ 9.99M | $ 4.92M | $ 0.00 |
| Total Debt | $ 0.00 | $ 0.00 | $ 498.60K | $ 0.00 | $ 0.00 |
| Net Debt | $ -916.92K | $ -4.17M | $ 457.80K | $ -4.09M | $ 0.00 |
| Total Liabilities | $ 3.00M | $ 180.70K | $ 2.92M | $ 5.96M | $ 0.00 |
| Stockholders' Equity | $ 143.73K | $ 4.27M | $ 7.07M | $ -1.04M | $ 0.00 |
| Cash Flow | |||||
| Free Cash Flow | $ -7.64M | $ -16.07M | $ -1.04M | $ -1.44M | $ -670.82K |
| Operating Cash Flow | $ -7.64M | $ -16.07M | $ -1.04M | $ -1.44M | $ -670.82K |
| Investing Cash Flow | $ 0.00 | $ 4.96M | $ 36.17M | $ -45.19M | $ 0.00 |
| Financing Cash Flow | $ -489.43K | $ 12.79M | $ -35.56M | $ 5.53M | $ 670.82K |
Estrella Immunopharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.